35
https://pubmed.ncbi.nlm.nih.gov/38115931
The use of tenofovir and entecavir for hepatitis B treatment has led to a significant decrease in the incidence of hepatocellular carcinoma.
https://pubmed.ncbi.nlm.nih.gov/38115931
The use of tenofovir and entecavir for hepatitis B treatment has led to a significant decrease in the incidence of hepatocellular carcinoma.